L.p. 667, - Net Worth and Insider Trading

L.p. 667, Net Worth

The estimated net worth of L.p. 667, is at least $19 Million dollars as of 2024-11-13. L.p. 667, is the Director of ACADIA Pharmaceuticals Inc and owns about 1,045,475 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $19 Million. Details can be seen in L.p. 667,'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that L.p. 667, has not made any transactions after 2013-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of L.p. 667,

To

L.p. 667, Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, L.p. 667, owns 21 companies in total, including IGM Biosciences Inc (IGMS) , Incyte Corp (INCY) , and Kodiak Sciences Inc (KOD) among others .

Click here to see the complete history of L.p. 667,’s form 4 insider trades.

Insider Ownership Summary of L.p. 667,

Ticker Comapny Transaction Date Type of Owner
IGMS IGM Biosciences Inc 2022-03-12 director & 10 percent owner
INCY Incyte Corp 2013-06-11 director
KOD Kodiak Sciences Inc 2022-01-21 director & 10 percent owner
LIMIT LIMIT 2022-06-17 director & 10 percent owner
LIMIT LIMIT 2022-06-29 director
LIMIT LIMIT 2016-02-02 director & 10 percent owner
LIMIT LIMIT 2013-01-18 director
LIMIT LIMIT 2020-12-31 director & 10 percent owner
LIMIT LIMIT 2020-05-14 director
LIMIT LIMIT 2020-03-16 director
LIMIT LIMIT 2015-08-07 10 percent owner
LIMIT LIMIT 2014-03-10 director
LIMIT LIMIT 2012-07-19 director
LIMIT LIMIT 2015-01-29 10 percent owner
LIMIT LIMIT 2013-08-01 10 percent owner
LIMIT LIMIT 2012-07-19 director
LIMIT LIMIT 2022-06-10 director & 10 percent owner
LIMIT LIMIT 2022-06-13 director & 10 percent owner
LIMIT LIMIT 2021-02-23 director
LIMIT LIMIT 2022-05-10 director & 10 percent owner
LIMIT LIMIT 2023-06-15 director

L.p. 667, Latest Holdings Summary

L.p. 667, currently owns a total of 1 stock. L.p. 667, owns 1,045,475 shares of ACADIA Pharmaceuticals Inc (ACAD) as of January 18, 2013, with a value of $19 Million.

Latest Holdings of L.p. 667,

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACAD ACADIA Pharmaceuticals Inc 2013-01-18 1,045,475 17.94 18,755,822

Holding Weightings of L.p. 667,


L.p. 667, Form 4 Trading Tracker

According to the SEC Form 4 filings, L.p. 667, has made a total of 0 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 0 shares on January 18, 2013, which brought L.p. 667, around $0.

Insider Trading History of L.p. 667,

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

L.p. 667, Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

L.p. 667, Ownership Network

Ownership Network List of L.p. 667,

No Data

Ownership Network Relation of L.p. 667,

Insider Network Chart

L.p. 667, Owned Company Details

What does IGM Biosciences Inc do?

Who are the key executives at IGM Biosciences Inc?

L.p. 667, is the director & 10 percent owner of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include Principal Accounting Officer Steven Weber , Chief Medical Officer Chris H Takimoto , and Chief Financial Officer Misbah Tahir .

IGM Biosciences Inc (IGMS) Insider Trades Summary

Over the past 18 months, L.p. 667, made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 37,229 shares made by Fred Schwarzer , a net sale of 16,027 shares made by Bruce Keyt , and a net sale of 12,086 shares made by Lisa Lynn Decker .

In summary, during the past 3 months, insiders sold 11,288 shares of IGM Biosciences Inc (IGMS) in total and bought 0 shares, with a net sale of 11,288 shares. During the past 18 months, 192,234 shares of IGM Biosciences Inc (IGMS) were sold and 1,130,933 shares were bought by its insiders, resulting in a net purchase of 938,699 shares.

IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

IGM Biosciences Inc Insider Transactions

No Available Data

L.p. 667, Mailing Address

Above is the net worth, insider trading, and ownership report for L.p. 667,. You might contact L.p. 667, via mailing address: 860 Washington Street, 3rd Floor, New York Ny 10014.